Follow Us:
Wednesday, May 18, 2022



‘India too may have acute hepatitis cases… Child specialists must stay alert’

May 08, 2022 8:00 am

Over the last three weeks, several cases of acute hepatitis or liver inflammation of unknown origin have been reported among children in the US and Europe. At least 17 of them needed a liver transplant and one died of the disease as per the World Health Organization. Dr SHIV KUMAR SARIN speaks to ANONNA DUTT about how the disease is different from the usual hepatitis, the possible reasons for its spread among children, and preventive measures that parents can take.

Hepatitis outbreak in children: explainer on adenovirus type 41, the possible culprit

May 05, 2022 1:57 pm

Viral hepatitis from infection by adenoviruses has only been reported previously as a rare complication.

UK: More links between common virus, hepatitis in children

April 27, 2022 6:33 pm

The usual viruses that cause infectious liver inflammation -- hepatitis A to E -- weren't detected in any of the 111 cases being investigated in the UK

World Hepatitis Day 2021: Follow these hygiene practices to stay away from the disease

July 28, 2021 1:58 pm

Hepatitis is a preventable disease, and you can stay safe by taking some specific measures

World Hepatitis Day: Understanding the ABCs of different viruses that cause the disease

July 27, 2021 3:47 pm

Acute hepatitis is initially characterised by a flu-like illness with symptoms like fatigue, nausea, vomiting, loss of appetite and body aches. After a few weeks, this is followed by jaundice, dark coloured urine and abdominal pain and discomfort caused by a painfully-enlarged liver

UK infected blood probe focuses on school where dozens died

June 22, 2021 10:01 am

Some 89 former students were infected with HIV or hepatitis as a result and less than a quarter of them are still alive.

New research: Hepatitis C drugs shown to inhibit coronavirus enzyme

November 19, 2020 11:15 am

Researchers looked at several well-known drug molecules for potential repurposing efforts. These included three hepatitis C protease inhibitors: telaprevir, narlaprevir and boceprevir.